When to seek medical advice : Patients should contact their GP, diabetes specialist nurse, or NHS 111 urgently if they experience: Severe, persistent abdominal pain, especially if radiating to the back (possible pancreatitis) Persistent vomiting (unable to keep down fluids for more than 24 hours) Signs of dehydration (extreme thirst, dry mouth, reduced urination, dizziness) Fever, jaundice, or right upper abdominal pain (possible gallbladder disease) If nausea significantly impacts their ability to maintain adequate nutrition These symptoms may warrant dose reduction, temporary treatment interruption, or switching to an alternative GLP-1 preparation with a potentially better tolerability profile
Based on patient reports, those who experience cramping typically notice first symptoms within 3-7 days of their initial injection or after a dose increase
In response to the rise in blood sugar you experience after eating a meal, GLP-1 receptor agonists like Ozempic help the pancreas produce more insulin to keep blood sugar levels from spiking
Glucagon-like peptide-1 (GLP-1) is an incretin hormone naturally produced by intestinal L-cells in response to nutrient intake
Next Steps for Patients If youre currently using compounded semaglutide or tirzepatide, its crucial to: Schedule a Consultation : Meet with your healthcare provider to discuss transitioning to FDA-approved medications